About Us

Pediatric Oncology

Barbara Buldini is an internationally recognized expert of pediatric acute leukemias laboratory diagnosis and response-to-therapy monitoring.

She is Associate Professor at the University of Padova, Italy (since 2021) and serves in the managerial position of Altissima Specialità-Referente di Branca Specialistica “Leukemia Diagnosis” (since 2020).

She is the PI of the Morphology and Flow Cytometry group at the Pediatric Onco-Hematology Laboratory in Padova, the AIEOP reference laboratory for the diagnosis (immunophenotype and DNA-index) and MFC-MRD assessment of childhood acute leukemias (since 2018).

She is the scientific director of immunophenotype and MFC-MRD in ALL at first diagnosis (AIEOP-BFM ALL trials), relapse (InterALL 2010), Infant ALL, and AML (AIEOP LAM 2013) (since 2012).

She is member of numerous national and international groups/associations/societies.

She coordinates the AIEOP-BFM-AML Flow MRD group with Professor Dworzak (standardization of MFC-MRD in pediatric AML-since 2011).

She has been delegated with Professor Dworzak by the European Pediatric AML Study Group (BFM/NOPHO/LAME/AIOEP/DCOG/BSPHO/UK) for defining “Response-to-treatment/MRD Immunophenotyping” in AML (since 2012).

She is a Member of the AIEOP-BFM Flow Network, which includes the principal national reference Laboratories of BFM and AIEOP, for the standardization of immunophenotype at Diagnosis and MFC-MRD in childhood ALL (since 2006).

She leads the Padua Lab as AIEOP-BFM partner unit in the training by MFC of ALLIC Labs, groups with limited economic resources that use essentially FC for monitoring MRD in ALL treatment (Argentina and Georgia).

She is member of the Trial Steering Committee of AIEOP-BFM ALL (since 2018) and AIEOP-BFM AML 2020 (since 2019) protocols.

She was Member for AIEOP of the iLTB (international leukemia/lymphoma target board) core team, coordinated by Princes Maxima Centrum (Utrecht), for Relapsed ALL that share and discuss cases with resistant Leukemia (2021-2022).

She is Member for AIEOP of the Federal Tumorboard (since March 2023).

She is Member of the ITCC ((Innovative Therapies for Children with Cancer) Hema Committee,Villejiuf, France) (since 2021).

She is an AIEOP Member in the Ponte di Legno Group (since 2018).

She coordinates an ongoing study for the Ponte di Legno group on ALL with Hypereosinophilia (since 2023)

She is member of the Gruppo di Lavoro (GdL) AIEOP “Biologia Cellulare e Molecolare” (since 2009); consultant of the GdL AIEOP LAnL (Acute non-Lymphoblastic Leukemia – since 2012) and LLA (acute lymphoblastic leukemia – since 2018).

She was member of the Board of Directors at AIEOP (2018-2021).

She is member of TDC_AIEOP-BFM_ALL_genetics team (since 2023).

She is Tutor in the “FlowInLab project” [ https://elearning.unipd.it/flowinlab/ ], Moodle-based web site developed in collaboration with DLM Office, University of Padua as a Flow Cytometry training service (since 2016).

She participated the ‘International Project Ambi Studio’ about Ambiguous Acute Leukemias, in collaboration with iBFM FLOW network (coordinated by Prof. O. Hrusak, Praga, Czech Republic), ALLIC e St. Jude’s Children Hospital, Memphis, Tennessee, USA.

Her academic activity involves teaching Pediatrics, active member of Department Board, and supervision of graduate and PhD students.

She performed clinical track at Clinic of Pediatric Hematology-Oncology, with special interest on hemopoietic stem cell transplantation, IRCCS Policlinico San Matteo, University of Pavia, Italy, 2005-2006.

She coordinates and collaborates to several national and international projects.